Skip to content
Call organization+971 4 379 6393
Clinical specialist

Janusz Jankowski, MD, PhD, FRCP

Consultant Gastroenterologist · BiongevityBarrett's esophagus, GI cancer prevention, GERD, endoscopic management, metabolic liver disease

Reflux, Barrett's esophagus, GI cancer prevention, fatty liver, and evidence-heavy gastroenterology

View the practiceSource profileCredentials checked
Portrait of Janusz Jankowski, MD PhD

At a glance

Visit type
In person
Years in practice
42
New patients
Accepting patients
Languages
English

Practice

About

Janusz Jankowski is a consultant gastroenterologist with more than four decades in gastroenterology, cancer prevention, nutrition, and clinical trials. His training spans Glasgow, London, Oxford, Dundee, and Cambridge, and his research profile is unusually deep for a Dubai clinic: the AspECT trial in The Lancet, later work on Barrett's surveillance, 447 ResearchGate-listed publications, and 30,000+ citations. At Biongevity, that background is most relevant for reflux, Barrett's esophagus, GI cancer prevention, fatty liver, and metabolic digestive risk.

Approach

Signature approach

Jankowski brings a prevention-first gastroenterology lens. For reflux, Barrett's esophagus, family GI-cancer risk, obesity, or fatty-liver patterns, the visit is about understanding trajectory: what needs surveillance, what can be modified, and where chemoprevention, nutrition, endoscopy, or metabolic care should sit. He is especially useful when trial-level evidence needs to become practical GI risk planning.

What sets them apart

  • AspECT trial leadership. His Barrett's esophagus chemoprevention work helped define how high-dose PPI and aspirin strategies are discussed for the right patients.
  • Research depth. 447 listed publications, 30,000+ citations, major GI oncology textbook work, and $100M+ in grant history give him rare academic weight in a clinic setting.
  • GI cancer prevention focus. Reflux, Barrett's, nutrition, obesity, fatty liver, and surveillance strategy all connect to a coherent prevention focus.

Focus

Specialties

GI & Gut HealthCancer Prevention & ScreeningMetabolic Health

Who they see

Men 40+Adults 65+General Adult LongevityPost-Cancer Patients

Conditions treated

  • Chronic acid reflux / heartburn
    Gastroesophageal reflux disease (GERD)
  • Barrett's esophagus
    Barrett's esophagus (intestinal metaplasia)
  • Concern about esophageal or GI cancer risk
    GI cancer prevention and screening
  • Fatty liver disease
    Non-alcoholic fatty liver disease (NAFLD) / metabolic-associated steatotic liver disease (MASLD)
  • Digestive issues needing endoscopy
    Endoscopic management of gastrointestinal diseases
  • Diet and nutrition for cancer prevention
    Nutritional oncology / chemoprevention

Training

Education

  • MB ChB
    University of Glasgow
  • PhD, Research
    University of London (1996)
  • MD, Research
    University of Dundee (1995)
  • PCME
    University of Cambridge
  • MSc, Clinical Trials
    University of Oxford (2008)

Board certifications

  • FRCP

    Royal College of Physicians (London)

    Senior fellowship at the UK's principal physicians' college, awarded to consultants with sustained achievement in clinical practice and research.

  • FRCP(E)

    Royal College of Physicians (Edinburgh)

    Fellowship at the Edinburgh college, granted to physicians who have made significant contributions to medicine.

  • FACG

    American College of Gastroenterology

    Fellowship from the leading US gastroenterology society, recognizing demonstrated excellence in clinical practice and research.

Additional certifications

  • AGAF (AGA Fellow)

    American Gastroenterological Association

    Fellowship from the American Gastroenterological Association, recognizing outstanding contributions to gastroenterology research or education.

  • SFHEA (Senior Fellow)

    Higher Education Academy (UK)

    Senior fellowship from the UK's higher education professional body, recognizing sustained impact on university teaching and supervision.

Protocols

  • Upper gi endoscopy
  • Barrett's esophagus surveillance
  • Chemoprevention protocols (ppi + aspirin)
  • Nutritional cancer prevention programs
  • Precision gastroenterology diagnostics
  • Microbiome analysis

Published work

Publications

  • The Lancet, 2018
  • Barrett's Oesophagus Surveillance versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial
    Gastroenterology, 2025
  • Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus
    Nature Genetics, 2012
  • Polymorphisms Near TBX5 and GDF7 are Associated with Increased Risk for Barrett's Esophagus
    Gastroenterology, 2014
  • Diagnosis and management of Barrett's oesophagus
    BMJ, 2010
and 442 more publications

Elsewhere

Profiles

Before You Book

  • Care focus. Reflux, Barrett's esophagus, GI cancer risk, fatty liver, or digestive prevention questions that benefit from a research-heavy specialist.
  • Dubai consults. Patient visits are in person in Dubai, with additional academic and advisory roles outside the clinic.
  • Availability may vary. He is also publicly listed with Clemenceau Medical Center Dubai, so confirm Biongevity appointment timing before planning around him.

Verification

Profile updated
Credentials checked
Affiliations verified

Primary sourcehttps://biongevity.com/prof-dr-janusz-jankowski-md-phd/

Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.